Contact Us

Rett Syndrome Research Trust Advisor Makes Significant Discovery With Potential For Novel Therapeutic Approaches - February 2009

< Back to Previous Page

[Source: Medical News Today]

A paper published online in Nature Neuroscience reveals the presence of methyl CpG binding protein 2 (MeCP2) in glia. MeCP2 is a protein associated with a variety of neurological disorders, including Rett Syndrome, the most physically disabling of the autism spectrum disorders. The researchers show that MeCP2-deficient astrocytes (a subset of glia) stunt the growth of neighboring neurons. Remarkably, these neurons can recover when exposed to normal glia in culture.


Read More about this Study on Medical News Today

Tags: News of the Week Rett Syndrome February 2009